Usefulness of presepsin in the diagnosis of sepsis in patients with or without acute kidney injury

被引:63
作者
Nakamura, Yoshihiko [1 ]
Ishikura, Hiroyasu [1 ]
Nishida, Takeshi [1 ]
Kawano, Yasumasa [1 ]
Yuge, Rie [1 ]
Ichiki, Reiko [1 ]
Murai, Akira [1 ]
机构
[1] Fukuoka Univ, Fac Med, Dept Emergency & Crit Care Med, Jonan Ku, Fukuoka 8140180, Japan
来源
BMC ANESTHESIOLOGY | 2014年 / 14卷
关键词
Presepsin; Acute kidney injury; RIFLE criteria; Sepsis; Diagnosis; ACUTE-RENAL-FAILURE; INFLAMMATORY RESPONSE; QUALITY; THERAPY; SIRS; CARE;
D O I
10.1186/1471-2253-14-88
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Presepsin is useful for differentiating sepsis from non-infection related systemic inflammatory response syndrome. However, there are no studies investigating the usefulness of presepsin in diagnosing sepsis involving patients with acute kidney injury (AKI). The purpose of this study is to determine levels of blood presepsin in patients with or without sepsis and among non-AKI patients or patients with different degrees of AKI severity. Methods: This is a single center retrospective study. 247 patients admitted to the ICU between June 2010 and October 2012 were analyzed for their presepsin levels. We classified the patients into non-AKI and AKI according to the RIFLE (Risk, Injury, Failure, and Loss of kidney function and End-stage kidney disease or simply Loss and ESKD) criteria. We then sub-classified the patients in each group into either non-sepsis or sepsis sub-group and analyzed the accuracy of diagnosing sepsis based on their levels of presepsin. Results: The number of patients for each group was: non-AKI, 112; under AKI: Risk, 50; Injury, 36; Failure, 42; Loss and ESKD, 7. The levels of presepsin in sepsis groups were significantly higher than that in the non-sepsis group among the non-AKI, Risk and Injury patients (p < 0.0001, p < 0.01, p < 0.01, respectively). However, no significant difference in the level of presepsin between non-sepsis and sepsis groups among patients with Failure. In the receiver operating characteristic (ROC) analysis, the area under the curve (AUC) was 0.784 in the non-AKI group and 0.698 in the AKI comprising Risk, Injury and Failure groups. AUC value for non-AKI was not significantly different from that of AKI (p = 0.200). When 670 pg/mL was used as the cutoff value for presepsin, sensitivity and specificity were 70.3% and 81.3%, respectively. When 864 pg/mL was used as the cutoff value for presepsin, sensitivity and specificity were 71.4% and 63.8%, respectively. Conclusions: Presepsin level can be a reliable indicator of sepsis not only among non-AKI patients but also patients with less severe forms of AKI. However, it may not be a reliable indicator of sepsis in patients with a more advanced form of AKI.
引用
收藏
页数:7
相关论文
共 23 条
  • [1] Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia
    Abe, Ryuzo
    Oda, Shigeto
    Sadahiro, Tomohito
    Nakamura, Masataka
    Hirayama, Yo
    Tateishi, Yoshihisa
    Shinozaki, Koichiro
    Hirasawa, Hiroyuki
    [J]. CRITICAL CARE, 2010, 14 (02):
  • [2] Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia - Link between quality of care and resource utilization
    Battleman, DS
    Callahan, M
    Thaler, HT
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (06) : 682 - 688
  • [3] Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
    Bellomo, R
    Ronco, C
    Kellum, JA
    Mehta, RL
    Palevsky, P
    [J]. CRITICAL CARE, 2004, 8 (04): : R204 - R212
  • [4] Newer diagnostic tests for bacterial diseases
    Bhatia, B. D.
    Basu, Sriparna
    [J]. INDIAN JOURNAL OF PEDIATRICS, 2007, 74 (07) : 673 - 677
  • [5] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [6] Christ-Crain M, 2005, SWISS MED WKLY, V135, P451
  • [7] Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study
    Endo, Shigeatsu
    Suzuki, Yasushi
    Takahashi, Gaku
    Shozushima, Tatsuyori
    Ishikura, Hiroyasu
    Murai, Akira
    Nishida, Takeshi
    Irie, Yuhei
    Miura, Masanao
    Iguchi, Hironobu
    Fukui, Yasuo
    Tanaka, Kimiaki
    Nojima, Tsuyoshi
    Okamura, Yoshikazu
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2012, 18 (06) : 891 - 897
  • [8] Furusako S, 2008, United States patent, Patent No. [US7465547 B2, 7465547]
  • [9] Furusako S, 2009, United States patent, Patent No. [US7608684 B2, 7608684, US7,608,684 B2]
  • [10] Inflammatory markers in SIRS, sepsis and septic shock
    Herzum, I.
    Renz, H.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2008, 15 (06) : 581 - 587